Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma, Transitional Cell × durvalumab × Clear all

Phase

Phase 2 6 Phase 1/2 2 Phase 3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 9 Small Cell Lung Carcinoma 9 Carcinoma, Hepatocellular 9 Neoplasm Metastasis 8 Breast Neoplasms 8 Colorectal Neoplasms 7 Pancreatic Neoplasms 6 Ovarian Neoplasms 6 Melanoma 6 Advanced Solid Tumors 6 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Cholangiocarcinoma 4 Carcinoma, Renal Cell 4 Biliary Tract Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Neoplasms 3 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Head and Neck Neoplasms 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Solid Tumor 2 Primary Myelofibrosis 2 Lymphoma, Follicular 2 Liver Neoplasms 2

Interventions

pembrolizumab 20 Nivolumab 13 enfortumab vedotin 5 avelumab 5 atezolizumab 5 Magnetic Resonance Spectroscopy 5 Ipilimumab 4 fludarabine 3 cabozantinib 3 Specimen Handling 3 Docetaxel 3 Cyclophosphamide 3 Carboplatin 3 Pemetrexed 2 Interleukin-2 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 FAPI-46 2 Disulfides 2 Cisplatin 2 vinflunine 1 valrubicin 1 trastuzumab deruxtecan 1 toripalimab 1 temsirolimus 1 sotigalimab 1 soluble LAG-3 protein, human 1 sargramostim 1 relatlimab 1 poly ICLC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05154994 2026-01-27

RESOLVE

University of Utah

Phase 1 Active not recruiting

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡